Prevalence of aortic stenosis and TAVR outcomes in patients with systemic sclerosis‐associated pulmonary hypertension

There is little known about performing transcatheter aortic valve replacement (TAVR) in patients with group 1 pulmonary arterial hypertension (PAH) on advanced pulmonary vasodilator therapy. Retrospective cohort study among 90 patients with systemic sclerosis‐associated pulmonary arterial hypertensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Alman, Kirsten, Sadd, Corey J., Ravel, Amish, Raza, Farhan, Chybowski, Amy, Runo, James R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400580/
https://www.ncbi.nlm.nih.gov/pubmed/36034401
http://dx.doi.org/10.1002/pul2.12118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9400580/
https://www.ncbi.nlm.nih.gov/pubmed/36034401
http://dx.doi.org/10.1002/pul2.12118

Ejemplares similares